Mammalian Histidine Decarboxylase: from Structure to Function Aurelio A

Total Page:16

File Type:pdf, Size:1020Kb

Mammalian Histidine Decarboxylase: from Structure to Function Aurelio A Review articles Mammalian histidine decarboxylase: from structure to function Aurelio A. Moya-Garcia, Miguel A´ ngel Medina, and Francisca Sa´ nchez-Jime´ nez* Summary a complete picture of histamine metabolism, contributions of Histamine is a multifunctional biogenic amine with different processes should be considered, including histamine relevant roles in intercellular communication, inflamma- synthesis, degradation, storage into vesicles, secretion from tory processes and highly prevalent pathologies. Hista- the histamine-producing cells and reception by the target mine biosynthesis depends on a single decarboxylation (2) step, carried out by a PLP-dependent histidine decarbox- cells. The latter is, by far, the best-characterized process. In ylase activity (EC 4.1.1.22), an enzyme that still remains to fact, nowadays, most of the anti-histaminic drugs interfere with be fully characterized. Nevertheless, during the last few reception systems.(12) years, important advances have been made in this field, Nevertheless, interest in the enzyme responsible for hista- including the generation and validation of the first three- mine synthesis, histidine decarboxylase (HDC, EC.4.1.1.22) dimensional model of the enzyme, which allows us to revisit previous results and conclusions. This essay has increased due to recent findings. HDC knockout animals provides a comprehensive review of the current knowl- exhibit altered mast cell development and increased bone edge of the structural and functional characteristics formation:loss ratio, among other symptoms.(6,13) In addition, BioEssays of mammalian histidine decarboxylase. new interesting relationships have been established between 27:57–63, 2005. ß 2004 Wiley Periodicals, Inc. HDC expression and growth of different carcinoma types and neuroendocrine tumours.(14–18) All of these recent results Introduction indicate that HDC can be a potential target for therapeutical Histamine plays important roles during immune responses,(1,2) intervention of many inflammatory diseases, some neurologi- modulates gastric acid secretion(3,4) and is considered as a cal and neuroendocrine diseases, osteoporosis and even neurotransmitter involved in memory, appetite and circadian several types of neoplasias. However, the full characterization rhythm regulation.(5–7) Histamine has also been described as of this enzyme has presented many problems, which have a modulator of cell growth.(8–10) Thus, impairment of histamine prevented the development of more efficient HDC inhibitors metabolism is related to highly prevalent pathologies such as that can be used pharmacologically. Up to now, substrate many inflammatory responses, peptic ulcer, schizophrenia analogues (the suicide inhibitor a-fluoromethylhistidine, and tumour progression, among others.(5–11) In order to have among others) have been useful for basic research on histamine physiology and molecular biology.(13,19–22) In mammals and Gram-negative bacteria, HDCs are PLP- dependent enzymes. Initially, it was deduced that the mam- Department of Molecular Biology and Biochemistry. Faculty of malian native enzyme should be a homodimer (53–54 kDa/ Sciences. University of Ma´laga, Spain (23–25) Funding agency: This work was supported by SAF2002-2586 (MCyT, subunit). When mammalian HDC cDNAs were se- Spain), and REMA (FIS-ISCIII, Spain), and is part of the activities of quenced, it was noticed that the messengers should encode the National Institute of Bioinformatics (GNV-5, Genoma-Espan˜a 74 kDa polypeptides, thus indicating the occurrence of Foundation). processing mechanisms.(26,27) Then, different active HDC *Correspondence to: Dr Francisca Sa´nchez-Jime´nez, Department of versions (53–74 kDa/subunit) have also been reported to Molecular Biology and Biochemistry. Faculty of Sciences. University of (28–32) Ma´laga. 29071 Ma´laga. E-mail: [email protected] occur in vivo. The first mammalian HDC gene (the (33) DOI 10.1002/bies.20174 human one) was reported in 1994. There is a unique Published online in Wiley InterScience (www.interscience.wiley.com). gene per haploid genome.(34) Alternative splicing of HDC gene transcripts has been reported; however, this does not seem to cause the different isoforms found in vivo, either.(35) Most of the studies on mammalian HDC transcriptional Abbreviations: HDC (histidine decarboxylase), DDC (dopa decar- 0 regulation were devoted to characterizing mechanisms boxylase or aromatic L-amino acid decarboxylase), PLP (pyridoxal 5 - phosphate), 3D (three-dimensional), C terminus (carboxy-terminus), operating in normal and neoplastic gastric cells under different N terminus (amino-terminus). stimuli and circumstances (gastrin, Helicobacter pilori infec- tion, oxidative stress, etc).(4,14,36,37) Nevertheless, important BioEssays 27:57–63, ß 2004 Wiley Periodicals, Inc. BioEssays 27.1 57 Review articles species- and cell-type specificities must exist to control the cofactor forms a Schiff’s base with the e-amino group of a mammalian HDC transcription, but little information is avail- lysine residue of the enzyme (internal aldimine, holoenzyme). able on them at the molecular level.(38) There is also evidence After substrate binding into the catalytic site, a transaldimina- of differential HDC expression depending on the differentia- tion reaction occurs (step I in Fig. 1), so that the cofactor tion/developmental stage.(6,39) Zhao and coworkers have changes to be bound to the alpha-amino group of the substrate reported that HDC can also be regulated at translational level (external aldimine). Then, after an irreversible decarboxylation in an important extent.(21) This work also claims the finding of (step II in Fig. 1) and the occurrence of different PLP-product a histamine auto-feedback inhibition on HDC in enterochro- intermediates, the internal aldimine is finally recovered by a maffin-like cells. new transaldimination reaction and the amine product is In the last few years, advances have been carried out to liberated (step III in Fig. 1). Nevertheless, the different L-amino understand structural, mechanistic and post-translational acid decarboxylases can differ in the major tautomeric aspects of mammalian HDC. This review, the first on forms of the reaction intermediates, in the rates of their structure–function relationships of this enzyme, summarizes sequential transformation and, of course, in the ligand(s) this information and gives insights into the control of both accepted as substrate(s). These properties can be deduced the activity and quantity of the protein responsible for the from changes in the spectral properties of the PLP adduct histamine synthesis in mammalian cells. along the reaction.(41–43) The kinetic properties of mammalian histidine decarbox- Characteristics of mammalian HDC activity ylase have been recently studied by different biophysical All known PLP-dependent L-amino acid decarboxylases approaches on a recombinant version of the rat enzyme.(44) follow a common reaction mechanism, extensively reviewed Its kinetic constants (Km and kcat) are very similar to those by Hayashi.(40) Fig. 1 shows a simplified scheme of the HDC reported for the mammalian enzyme isolated from natural reaction. In the absence of substrate, the aldehyde group of sources.(23–25,45) Mammalian HDCs, as well as PLP-dependent Figure 1. The mammalian histidine decarbox- ylase reaction. The structures of the internal aldimine and representative PLP-substrate and PLP-product adducts are specified. ‘‘T’’ indicates transaldimination reactions during steps I and III. 58 BioEssays 27.1 Review articles HDCs from Gram-negative bacteria, have affinity constants in DDC) was reported.(52) The first 480 residues of mammalian the 0.2–1.5 mM range. However, these two groups greatly HDC, more than 50% identical to those of pig DCC, are able to differ (2–3 order of magnitude) in their kcat values as well as in conform an active enzyme.(32) Consequently, a HDC 3D the major tautomeric form of the holoenzyme. model generated by comparative modeling techniques (using Mammalian HDC is also less efficient than the highly pig DDC as the template) should represent an active form of homologous mammalian DDC, a paralogous enzyme that is the enzyme.(53) The first 3D model of a rat HDC dimer also able to accept histamine as a low-affinity substrate. (fragment 5–479) has been generated and strongly supported Both enzymes show major aldimine tautomeric forms for the by experimental results.(22,54) A solvated version of this model respective holoenzymes and ketoenamine tautomeric forms is used here for Figs. 2 and 3. for the respective PLP substrate (external aldimine) com- In the holoenzyme, PLP should be located between plexes, suggesting changes in the polarities of the cofactor residues K308 and H197 and covalently bound to the former environment during reaction. However, in the case of mam- (Fig. 2A). The predicted quaternary structure of rat HDC dimer malian HDC, it has been observed that histidine entrance (step follows a two-fold axial symmetry pattern similar to that 1 in Fig. 1) involves an important rotation of the cofactor, which reported for the crystal structure of pig DDC (Fig. 2B), so two presents a diminished conjugation between the imine and the catalytic sites are conformed by the dimer interface. Each PLP pyridine ring in the external aldimine state as compared to the binding site mainly involves residues of one monomer (most other homologous enzymes mentioned above. This could of them located in the fragment 276–308); however, the explain the extremely
Recommended publications
  • Neurotransmitter Resource Guide
    NEUROTRANSMITTER RESOURCE GUIDE Science + Insight doctorsdata.com Doctor’s Data, Inc. Neurotransmitter RESOURCE GUIDE Table of Contents Sample Report Sample Report ........................................................................................................................................................................... 1 Analyte Considerations Phenylethylamine (B-phenylethylamine or PEA) ................................................................................................. 1 Tyrosine .......................................................................................................................................................................................... 3 Tyramine ........................................................................................................................................................................................4 Dopamine .....................................................................................................................................................................................6 3, 4-Dihydroxyphenylacetic Acid (DOPAC) ............................................................................................................... 7 3-Methoxytyramine (3-MT) ............................................................................................................................................... 9 Norepinephrine ........................................................................................................................................................................
    [Show full text]
  • Decarboxylation What Is Decarboxylation?
    Decarboxylation What is decarboxylation? Decarboxylation is the removal of a carboxyl group when a compound is exposed to light or heat. A carboxyl group is a grouping of carbon, oxygen, and hydrogen atoms in the form of COOH. When a compound is decarboxylated, this group is released in the form of carbon dioxide. Decarboxylation of cannabinoids When considering the decarboxylation of cannabinoids, it is important to note that this reaction is what causes the neutral acidic cannabinoids to turn into the active cannabinoids found in most products on the market. Both the neutral and acidic cannabinoids are naturally found in the cannabis plant. The active cannabinoids that have psychoactive properties are what occur after decarboxylation. Below is the mechanism for the conversion of THCA to THC. https://www.leafscience.com/2017/04/13/what-is-thca/ Heating THCA converts it to THC by kicking off the carboxyl group seen on the right side of the THCA molecule. Once the carboxyl group is released from the THCA it forms carbon dioxide and the THC compound. The THC is now ready for use in different products and will provide the psychoactive effects that popularized this compound. This simple reaction is all it takes to convert the acidic cannabinoids to their active counterparts. Cannabinolic acid (CBDA) and CBD are both another example of this process. Decarboxylation process Light can start the decarboxylation process after a period of time, but heat is the more common element used. There are different methods to decarboxylate cannabis depending on user preference. In the industry, dabs, vapes and joints decarboxylate instantly when heat is applied to the product.
    [Show full text]
  • Optimization of the Decarboxylation Reaction in Cannabis
    APPLICATION NOTE FT-IR Spectroscopy Authors: Dr. Markus Roggen1 Antonio M. Marelli1 Doug Townsend2 Ariel Bohman2 1Outco SanDiego, CA 2PerkinElmer, Inc. Shelton, CT. Optimization of the Decarboxylation Reaction Introduction The production of cannabis in Cannabis Extract extracts and oils for medicinal and recreational products has increased significantly in North America. This growth has been driven by both market demand in newly legalized states and patient demand for a greater diversity in cannabis products.1,2,3 Most cannabis extraction processes, independent of solvent or instrument choice, undergo a decarboxylation step whereby the carboxylic acid functional group is removed from the cannabinoids. The decarboxylation reaction converts the naturally occurring acid forms of the cannabinoids, e.g. tetrahydrocannabinolic acid (THCA) and cannabidiolic acid (CBDA), to their more potent neutral forms, e.g. tetrahydrocannabinol (THC) and cannabidiol (CBD). Because the carboxylic acid group is thermally labile, the industry typically applies a heat source, and at times a catalyst, to decarboxylate the cannabinoids. The heat-promoted decarboxylation reaction has been Decarboxylation Reaction discussed at length within the industry, but an extensive Decarboxylation was achieved by heating the cannabis extract in 4, 5, 6 literature search reveals very few papers on the process. a oil bath with a programmable hot plate. An overhead stirrer The data available represents a large spectrum of reaction was utilized to promote even heat distribution throughout the conditions, including a range in reaction temperature, time experiment. Oil bath and extract temperatures were recorded and instrumental setup. As such, there is a lack of universal every five minutes throughout the 80-minute heating process.
    [Show full text]
  • Histidine Decarboxylase Knockout Mice Production and Signal
    Nitric Oxide Mediates T Cell Cytokine Production and Signal Transduction in Histidine Decarboxylase Knockout Mice This information is current as Agnes Koncz, Maria Pasztoi, Mercedesz Mazan, Ferenc of October 1, 2021. Fazakas, Edit Buzas, Andras Falus and Gyorgy Nagy J Immunol 2007; 179:6613-6619; ; doi: 10.4049/jimmunol.179.10.6613 http://www.jimmunol.org/content/179/10/6613 Downloaded from References This article cites 41 articles, 8 of which you can access for free at: http://www.jimmunol.org/content/179/10/6613.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 1, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2007 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology Nitric Oxide Mediates T Cell Cytokine Production and Signal Transduction in Histidine Decarboxylase Knockout Mice1 Agnes Koncz,*† Maria Pasztoi,* Mercedesz Mazan,* Ferenc Fazakas,‡ Edit Buzas,* Andras Falus,*§ and Gyorgy Nagy2,3*¶ Histamine is a key regulator of the immune system.
    [Show full text]
  • Aldrich Raman
    Aldrich Raman Library Listing – 14,033 spectra This library represents the most comprehensive collection of FT-Raman spectral references available. It contains many common chemicals found in the Aldrich Handbook of Fine Chemicals. To create the Aldrich Raman Condensed Phase Library, 14,033 compounds found in the Aldrich Collection of FT-IR Spectra Edition II Library were excited with an Nd:YVO4 laser (1064 nm) using laser powers between 400 - 600 mW, measured at the sample. A Thermo FT-Raman spectrometer (with a Ge detector) was used to collect the Raman spectra. The spectra were saved in Raman Shift format. Aldrich Raman Index Compound Name Index Compound Name 4803 ((1R)-(ENDO,ANTI))-(+)-3- 4246 (+)-3-ISOPROPYL-7A- BROMOCAMPHOR-8- SULFONIC METHYLTETRAHYDRO- ACID, AMMONIUM SALT PYRROLO(2,1-B)OXAZOL-5(6H)- 2207 ((1R)-ENDO)-(+)-3- ONE, BROMOCAMPHOR, 98% 12568 (+)-4-CHOLESTEN-3-ONE, 98% 4804 ((1S)-(ENDO,ANTI))-(-)-3- 3774 (+)-5,6-O-CYCLOHEXYLIDENE-L- BROMOCAMPHOR-8- SULFONIC ASCORBIC ACID, 98% ACID, AMMONIUM SALT 11632 (+)-5-BROMO-2'-DEOXYURIDINE, 2208 ((1S)-ENDO)-(-)-3- 97% BROMOCAMPHOR, 98% 11634 (+)-5-FLUORODEOXYURIDINE, 769 ((1S)-ENDO)-(-)-BORNEOL, 99% 98+% 13454 ((2S,3S)-(+)- 11633 (+)-5-IODO-2'-DEOXYURIDINE, 98% BIS(DIPHENYLPHOSPHINO)- 4228 (+)-6-AMINOPENICILLANIC ACID, BUTANE)(N3-ALLYL)PD(II) CL04, 96% 97 8167 (+)-6-METHOXY-ALPHA-METHYL- 10297 ((3- 2- NAPHTHALENEACETIC ACID, DIMETHYLAMINO)PROPYL)TRIPH 98% ENYL- PHOSPHONIUM BROMIDE, 12586 (+)-ANDROSTA-1,4-DIENE-3,17- 99% DIONE, 98% 13458 ((R)-(+)-2,2'- 963 (+)-ARABINOGALACTAN BIS(DIPHENYLPHOSPHINO)-1,1'-
    [Show full text]
  • 1 Abietic Acid R Abrasive Silica for Polishing DR Acenaphthene M (LC
    1 abietic acid R abrasive silica for polishing DR acenaphthene M (LC) acenaphthene quinone R acenaphthylene R acetal (see 1,1-diethoxyethane) acetaldehyde M (FC) acetaldehyde-d (CH3CDO) R acetaldehyde dimethyl acetal CH acetaldoxime R acetamide M (LC) acetamidinium chloride R acetamidoacrylic acid 2- NB acetamidobenzaldehyde p- R acetamidobenzenesulfonyl chloride 4- R acetamidodeoxythioglucopyranose triacetate 2- -2- -1- -β-D- 3,4,6- AB acetamidomethylthiazole 2- -4- PB acetanilide M (LC) acetazolamide R acetdimethylamide see dimethylacetamide, N,N- acethydrazide R acetic acid M (solv) acetic anhydride M (FC) acetmethylamide see methylacetamide, N- acetoacetamide R acetoacetanilide R acetoacetic acid, lithium salt R acetobromoglucose -α-D- NB acetohydroxamic acid R acetoin R acetol (hydroxyacetone) R acetonaphthalide (α)R acetone M (solv) acetone ,A.R. M (solv) acetone-d6 RM acetone cyanohydrin R acetonedicarboxylic acid ,dimethyl ester R acetonedicarboxylic acid -1,3- R acetone dimethyl acetal see dimethoxypropane 2,2- acetonitrile M (solv) acetonitrile-d3 RM acetonylacetone see hexanedione 2,5- acetonylbenzylhydroxycoumarin (3-(α- -4- R acetophenone M (LC) acetophenone oxime R acetophenone trimethylsilyl enol ether see phenyltrimethylsilyl... acetoxyacetone (oxopropyl acetate 2-) R acetoxybenzoic acid 4- DS acetoxynaphthoic acid 6- -2- R 2 acetylacetaldehyde dimethylacetal R acetylacetone (pentanedione -2,4-) M (C) acetylbenzonitrile p- R acetylbiphenyl 4- see phenylacetophenone, p- acetyl bromide M (FC) acetylbromothiophene 2- -5-
    [Show full text]
  • Citric Acid Cycle
    CHEM464 / Medh, J.D. The Citric Acid Cycle Citric Acid Cycle: Central Role in Catabolism • Stage II of catabolism involves the conversion of carbohydrates, fats and aminoacids into acetylCoA • In aerobic organisms, citric acid cycle makes up the final stage of catabolism when acetyl CoA is completely oxidized to CO2. • Also called Krebs cycle or tricarboxylic acid (TCA) cycle. • It is a central integrative pathway that harvests chemical energy from biological fuel in the form of electrons in NADH and FADH2 (oxidation is loss of electrons). • NADH and FADH2 transfer electrons via the electron transport chain to final electron acceptor, O2, to form H2O. Entry of Pyruvate into the TCA cycle • Pyruvate is formed in the cytosol as a product of glycolysis • For entry into the TCA cycle, it has to be converted to Acetyl CoA. • Oxidation of pyruvate to acetyl CoA is catalyzed by the pyruvate dehydrogenase complex in the mitochondria • Mitochondria consist of inner and outer membranes and the matrix • Enzymes of the PDH complex and the TCA cycle (except succinate dehydrogenase) are in the matrix • Pyruvate translocase is an antiporter present in the inner mitochondrial membrane that allows entry of a molecule of pyruvate in exchange for a hydroxide ion. 1 CHEM464 / Medh, J.D. The Citric Acid Cycle The Pyruvate Dehydrogenase (PDH) complex • The PDH complex consists of 3 enzymes. They are: pyruvate dehydrogenase (E1), Dihydrolipoyl transacetylase (E2) and dihydrolipoyl dehydrogenase (E3). • It has 5 cofactors: CoASH, NAD+, lipoamide, TPP and FAD. CoASH and NAD+ participate stoichiometrically in the reaction, the other 3 cofactors have catalytic functions.
    [Show full text]
  • Lecture: 28 TRANSAMINATION, DEAMINATION and DECARBOXYLATION
    Lecture: 28 TRANSAMINATION, DEAMINATION AND DECARBOXYLATION Protein metabolism is a key physiological process in all forms of life. Proteins are converted to amino acids and then catabolised. The complete hydrolysis of a polypeptide requires mixture of peptidases because individual peptidases do not cleave all peptide bonds. Both exopeptidases and endopeptidases are required for complete conversion of protein to amino acids. Amino acid metabolism The amino acids not only function as energy metabolites but also used as precursors of many physiologically important compounds such as heme, bioactive amines, small peptides, nucleotides and nucleotide coenzymes. In normal human beings about 90% of the energy requirement is met by oxidation of carbohydrates and fats. The remaining 10% comes from oxidation of the carbon skeleton of amino acids. Since the 20 common protein amino acids are distinctive in terms of their carbon skeletons, amino acids require unique degradative pathway. The degradation of the carbon skeletons of 20 amino acids converges to just seven metabolic intermediates namely. i. Pyruvate ii. Acetyl CoA iii. Acetoacetyl CoA iv. -Ketoglutarate v. Succinyl CoA vi. Fumarate vii. Oxaloacetate Pyruvate, -ketoglutarate, succinyl CoA, fumarate and oxaloacetate can serve as precursors for glucose synthesis through gluconeogenesis.Amino acids giving rise to these intermediates are termed as glucogenic. Those amino acids degraded to yield acetyl CoA or acetoacetate are termed ketogenic since these compounds are used to synthesize ketone bodies. Some amino acids are both glucogenic and ketogenic (For example, phenylalanine, tyrosine, tryptophan and threonine. Catabolism of amino acids The important reaction commonly employed in the breakdown of an amino acid is always the removal of its -amino group.
    [Show full text]
  • In Vitro Pharmacology of Clinically Used Central Nervous System-Active Drugs As Inverse H1 Receptor Agonists
    0022-3565/07/3221-172–179$20.00 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS Vol. 322, No. 1 Copyright © 2007 by The American Society for Pharmacology and Experimental Therapeutics 118869/3215703 JPET 322:172–179, 2007 Printed in U.S.A. In Vitro Pharmacology of Clinically Used Central Nervous System-Active Drugs as Inverse H1 Receptor Agonists R. A. Bakker,1 M. W. Nicholas,2 T. T. Smith, E. S. Burstein, U. Hacksell, H. Timmerman, R. Leurs, M. R. Brann, and D. M. Weiner Department of Medicinal Chemistry, Leiden/Amsterdam Center for Drug Research, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands (R.A.B., H.T., R.L.); ACADIA Pharmaceuticals Inc., San Diego, California (R.A.B., M.W.N., T.T.S., E.S.B., U.H., M.R.B., D.M.W.); and Departments of Pharmacology (M.R.B.), Neurosciences (D.M.W.), and Psychiatry (D.M.W.), University of California, San Diego, California Received January 2, 2007; accepted March 30, 2007 Downloaded from ABSTRACT The human histamine H1 receptor (H1R) is a prototypical G on this screen, we have reported on the identification of 8R- protein-coupled receptor and an important, well characterized lisuride as a potent stereospecific partial H1R agonist (Mol target for the development of antagonists to treat allergic con- Pharmacol 65:538–549, 2004). In contrast, herein we report on jpet.aspetjournals.org ditions. Many neuropsychiatric drugs are also known to po- a large number of varied clinical and chemical classes of drugs tently antagonize this receptor, underlying aspects of their side that are active in the central nervous system that display potent effect profiles.
    [Show full text]
  • Biomedical Applications of Polymeric Cryogels
    applied sciences Review Biomedical Applications of Polymeric Cryogels Monireh Bakhshpour 1, Neslihan Idil 2, I¸sıkPerçin 2 and Adil Denizli 1,* 1 Department of Chemistry, Faculty of Science, Hacettepe University, Ankara 06800, Turkey; [email protected] 2 Department of Biology, Faculty of Science, Hacettepe University, Ankara 06800, Turkey; [email protected] (N.I.); [email protected] (I.P.) * Correspondence: [email protected]; Tel.: +90-312-297-7983 Received: 31 December 2018; Accepted: 4 February 2019; Published: 7 February 2019 Featured Application: This study presents the comprehensive applications of polymeric cryogels in the field of biomedicine. To the best of our knowledge, this review is one of the most pioneering paper comparatively explains the biomedical applications of cryogels in detail. Abstract: The application of interconnected supermacroporous cryogels as support matrices for the purification, separation and immobilization of whole cells and different biological macromolecules has been well reported in literature. Cryogels have advantages over traditional gel carriers in the field of biochromatography and related biomedical applications. These matrices nearly mimic the three-dimensional structure of native tissue extracellular matrix. In addition, mechanical, osmotic and chemical stability of cryogels make them attractive polymeric materials for the construction of scaffolds in tissue engineering applications and in vitro cell culture, separation materials for many different processes such as immobilization of biomolecules, capturing of target molecules, and controlled drug delivery. The low mass transfer resistance of cryogel matrices makes them useful in chromatographic applications with the immobilization of different affinity ligands to these materials. Cryogels have been introduced as gel matrices prepared using partially frozen monomer or polymer solutions at temperature below zero.
    [Show full text]
  • Dopa Decarboxylase Activity of the Living Human Brain
    Proc. Natl. Acad. Sci. USA Vol. 88, pp. 2721-2725, April 1991 Neurobiology Dopa decarboxylase activity of the living human brain (dopamine/dopamine synthesis/6-['8F]fluoro-L-dopa/Parkinson disease/positron emission tomography) ALBERT GJEDDE, JAKOB REITH, SUZAN DYVE, GABRIEL MGER, MARK GUTTMAN, MiRKo DIKSIC, ALAN EVANS, AND HIROTO KUWABARA Positron Imaging Laboratories, Montreal Neurological Institute, 3801 University Street, Montreal, Quebec H3A 2B4, Canada Communicated by Alfred P. Wolf, December 10, 1990 (received for review July 23, 1990) ABSTRACT Monoamiergic neurons use dopa decarbox- loss of methyl-Fdopa from the circulation, the methylation of ylase (DDC; aromatic-L-amino-acid carboxy-lyase, EC Fdopa in brain tissue, the exchange of Fdopa and methyl- 4.1.1.28) to form dopamine from L-3,4-dihydroxyphenylala- Fdopa between the circulation and brain tissue, and the nine (L-dopa). We measured regional dopa decarboxylase decarboxylation of Fdopa in the tissue. The model has too activity in brains of six healthy volunteers with 6-[18F]fluoro- many compartments to be evaluated by PET. We used known L-dopa and positron emission tomography. We calculated the relationships between the parameters to reduce the number enzyme activity, relative to its K., with a kinetic model that of compartments to three and the number of parameters to yielded the relative rate of conversion of 6['8Flfluoro-L-dopa four: We incorporated into each study (i) the ratio (0.43) to [18Fjfluorodopamine. Regional values of relative dopa de- between the blood-brain barrier transport rates ofFdopa and carboxylase activity ranged from nil in occipital cortex to 1.9 methyl-Fdopa in rat (5), (ii) the rate of conversion of Fdopa h-1 in caudate nucleus and putamen, in agreement with values to methyl-Fdopa and the rate of loss of methyl-Fdopa from obtained in vitro.
    [Show full text]
  • Phytochem Referenzsubstanzen
    High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.286. ABIETIC ACID Sylvic acid [514-10-3] 302.46 C20H30O2 01.030. L-ABRINE N-a-Methyl-L-tryptophan [526-31-8] 218.26 C12H14N2O2 Merck Index 11,5 01.031. (+)-ABSCISIC ACID [21293-29-8] 264.33 C15H20O4 Merck Index 11,6 01.032. (+/-)-ABSCISIC ACID ABA; Dormin [14375-45-2] 264.33 C15H20O4 Merck Index 11,6 01.002. ABSINTHIN Absinthiin, Absynthin [1362-42-1] 496,64 C30H40O6 Merck Index 12,8 01.033. ACACETIN 5,7-Dihydroxy-4'-methoxyflavone; Linarigenin [480-44-4] 284.28 C16H12O5 Merck Index 11,9 01.287. ACACETIN Apigenin-4´methylester [480-44-4] 284.28 C16H12O5 01.034. ACACETIN-7-NEOHESPERIDOSIDE Fortunellin [20633-93-6] 610.60 C28H32O14 01.035. ACACETIN-7-RUTINOSIDE Linarin [480-36-4] 592.57 C28H32O14 Merck Index 11,5376 01.036. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- a-D-Glucosamine pentaacetate 389.37 C16H23NO10 ACETYL-a-D-GLUCOPYRANOSE 01.037. 2-ACETAMIDO-2-DEOXY-1,3,4,6-TETRA-O- b-D-Glucosamine pentaacetate [7772-79-4] 389.37 C16H23NO10 ACETYL-b-D-GLUCOPYRANOSE> 01.038. 2-ACETAMIDO-2-DEOXY-3,4,6-TRI-O-ACETYL- Acetochloro-a-D-glucosamine [3068-34-6] 365.77 C14H20ClNO8 a-D-GLUCOPYRANOSYLCHLORIDE - 1 - High pure reference substances Phytochem Hochreine Standardsubstanzen for research and quality für Forschung und management Referenzsubstanzen Qualitätssicherung Nummer Name Synonym CAS FW Formel Literatur 01.039.
    [Show full text]